Blog
Jinseop Song · July 15, 2026
What we want to solve for the beauty industry
The two things we set out to fix: one home for all your work, and an AI system aimed at your real pain points.
Jinseop Song · July 16, 2026
How we take your data
How we isolate, minimize, and protect the data you bring into Tamats, stated honestly.
Jinseop Song · July 17, 2026
Who we are
A note from our founder, Jinseop Song, on why Tamats exists.
Jinseop Song · July 18, 2026
We are transparent
Transparency is a product principle at Tamats, not a slogan. Here is what that means in practice.
Jinseop Song · July 19, 2026
We want your feedback
We are early, and the roadmap is open. Tell us what you need and we will build it with you.
Jinseop Song · July 20, 2026
Case Study: How Korea's APR Is Beating Amorepacific and LG
How APR, the maker of Medicube, overtook a legacy giant on the strength of social-first marketing and a US-first global playbook, and what smaller brands can learn from it.
Jinseop Song · August 2, 2026
The MoCRA compliance checklist every cosmetics brand needs
Facility registration, product listing, safety substantiation, adverse-event reporting — the seven MoCRA obligations to check before your next US shipment, each linked to FDA's own guidance.
Jinseop Song · August 2, 2026
The EU's new rules on "eco-friendly" claims: a label-run checklist
Directive (EU) 2024/825 bans generic environmental claims without recognised proof, applying from 27 September 2026 — what it changes and the pre-deadline checklist for cosmetics labels.
Jinseop Song · August 2, 2026
Sourcing from a Korean ODM? A practical checklist before you sign
ODM vs OEM vs private label, the questions to settle before MOQ talk, and why compliance obligations — MoCRA responsible person, EU responsible person — don't ship in the box.